Immunocore Holdings plc (IMCR) Misses Q4 EPS by 65c

Immunocore Holdings plc (NASDAQ: IMCR) reported Q4 EPS of ($0.63), $0.65 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $58 million versus the consensus estimate of $43.37 million.

For earnings history and earnings-related data on Immunocore Holdings plc (IMCR) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Methode Electronics (MEI) Tops Q1 EPS by 2c; offers guidance
• NetApp (NTAP) Tops Q1 EPS by 47c, Beats on Revenue